| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |